Effects of performance enhancing drugs on the health of athletes and athletic competition: hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Sixth Congress, first session, October 20, 1999, Volumes 73-77

Front Cover
U.S. G.P.O., 2002 - Medical - 116 pages
0 Reviews

From inside the book

What people are saying - Write a review

We haven't found any reviews in the usual places.


Hearing held October 20 1999
Coleman Doriane Lambelet Professor Duke University School of Law 85
Serota Scott Executive Vice President and chief operating officer Blue Cross

4 other sections not shown

Other editions - View all

Common terms and phrases

Bibliographic information